Reply to Letter to the Editor "Addressing Gaps in Post-MI Medication Use Study" regarding: "Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia"
1 Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic, Australia; Pharmacy Department, Grampians Health, Ballarat, Vic, Australia. Electronic address: adam.livori1@monash.edu.
2 Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.
3 Victorian Heart Institute, Melbourne, Vic, Australia; Duke Clinical Research Institute, Duke University, Durham, NC, USA.
4 Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia; Monash Data Futures Institute, Monash University, Melbourne, Vic, Australia.
5 Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Vic, Australia; Department of Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Vic, Australia.